¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"specific type"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
age-specific rate
¿¬·Éº°ºñÀ²
cause-specific rate
¿øÀκ°ºñÀ²
donor-specific phage
Á¦°øÀÚÆ¯ÀÌÆÄÁö, °ø¿©ÀÚÆ¯ÀÌÆÄÁö
granulocyte-specific antigen
°ú¸³±¸Æ¯ÀÌÇ׿ø
group-specific
±ºÆ¯ÀÌ-
group-specific antigen
¹«¸®Æ¯ÀÌÇ׿ø, ±ºÆ¯ÀÌÇ׿ø
neuron-specific enolase
´º·±Æ¯ÀÌ¿¡³î¶ó¾ÆÁ¦
organ specific antigen
Àå±âƯÀÌÇ׿ø
platelet-specific antigen
Ç÷¼ÒÆÇƯÀÌÇ׿ø
prostate specific antigen
Àü¸³»ùƯÀÌÇ׿ø
species-specific
Á¾Æ¯ÀÌ-
species-specific antigen
Á¾Æ¯ÀÌÇ׿ø
species-specific reactivity
Á¾Æ¯À̹ÝÀÀ¼º
specific
1. ƯÀÌ-, ƯÁ¤- 2. Á¾-
specific absorption rate
ºñÈí¼öÀ²
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
specific marriage rate
ƯÀ̰áÈ¥À²
specific morbidity rate
ƯÀÌÀÌȯÀ²
specific mortality rate
ƯÀÌ»ç¸Á·ü
specific reading retardation
ƯÁ¤ÀбâÁö¿¬
specific
ƯÀÌ-, ƯÁ¤-
specific serum
ƯÀÌÇ÷û
specific gravity test
ºñÁß½ÃÇè
specific soluble substance
ƯÀ̰¡¿ë¹°Áú
virus-specific
¹ÙÀÌ·¯½ºÆ¯ÀÌ-
abortive type
ºÎÀüÇü
anovulatory type
¹«¹è¶õÇü
asthenic type
¹«·ÂüÇü
athletic type
°ÇÀåÇü
precision type attachment
Á¤¹ÐÇüºÎÂø
blood type
Ç÷¾×Çü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
growth onset type diabetes
Ãʱâ´ç´¢º´.
hebephrenic type
ÆÄ°úÇü(÷òÍþúþ)
hemochorial type
À¶Ç÷¸ðÇü(ëÖúìÙ¾úþ).
hemoglobin C type
CÇü Ç÷»ö¼Ò
hemoglobin E type
E Çü Ç÷»ö¼Ò
hepatitis,type a
A Çü
hepatitis,type b
B Çü
herpes simplex virus type 1
Á¦1Çü ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º
herpes simplex virus type 2
Á¦2Çü ´Ü¼øÆ÷Áø¹ÙÀÌ·¯½º
htlv,type i
type 1Çü
human T cell leukemia virus type I
Á¦1Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
human T cell leukemia virus type I
Á¦1Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
human T cell leukemia virus type II
Á¦2Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
human T cell leukemia virus type II
Á¦2Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
hyperlipoproteinemia type III
°íÁö´Ü¹éÇ÷Áõ III
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
specific blood group substance
ƯÀÌÇ÷¾×Çü¹°Áú(¡úìäûúþÚªòõ).
specific blood group substance
ƯÀÌÇ÷¾×Çü¹°Áú(¡úìäûúþÚªòõ)
specific blood group substance
ƯÀÌÇ÷¾×Çü¹°Áú(?Ì´ËâÌ´?̤).
specific capsular reaction
ƯÀÌÇù¸·¹ÝÀÀ (¡úõدÚãëë).
specific capsular reaction
ƯÀÌÇù¸·¹ÝÀÀ (¡úõدÚãëë).
specific cellular immunity
ƯÀÌÀû ¼¼Æ÷¸é¿ª (¡îÜá¬øàØóæ¹).
specific cellular immunity
ƯÀÌÀû ¼¼Æ÷¸é¿ª (¡îÜá¬øàØóæ¹).
specific charge
ºñÀüÇÏ(Ýïï³ùÃ).
specific compliance
ƯÀÌÀÀ¶ô(¡ëëÕ«).
specific conductivity
ºñÀüµµÀ²(ÝïîîÓôëÒ).
specific death rate
Ư¼ö<ƯÀÌ>»ç¸Á·ü.
specific developmental disorder of motor function
ƯÁ¤ ¿îµ¿±â´É ¹ß´ÞÀå¾Ö
specific developmental disorders of scholastic skill
ƯÁ¤ Çо÷±â¼ú ¹ß´ÞÀå¾Ö
specific developmental disorders of speech and languages
ƯÁ¤ ¸»Çϱâ¿Í ¾ð¾îÀÇ ¹ß´ÞÀå¾Ö
specific disease
ƯÀÌÁúȯ(¡òðü´)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½